Thytech — Pre-seed · €350K

Thytech raised €350,000 in its first investment round, led by Banco Sabadell's BStartup through the BStartup Health programme, with Genesis Biomed and private investors also participating. The money was earmarked for developing the thyTreg cell therapy, regulatory studies and the roadmap towards commercialisation; Crunchbase records the round as pre-seed and quotes it as about $387K.